Testosterone deficiency in men. Diagnosis and management
- PMID: 12833767
Testosterone deficiency in men. Diagnosis and management
Abstract
Background: Testosterone deficiency (hypoandrogenism) is the commonest hormonal deficiency in men but its clinical presentation may be subtle and its diagnosis overlooked unless actively considered.
Objective: This article aims to provide an overview of the presentation of hypoandrogenism and the essential diagnostic role of the endocrine laboratory. We also seek to outline current treatment options and highlight the controversial area of age related hypoandrogenism with an emphasis on results from placebo controlled studies.
Discussion: The causes of hypogonadism in younger men are well documented but its presentation may be nonspecific and the diagnosis in older men may be difficult. It is likely that testosterone deficiency is widely under diagnosed. Endocrine testing provides essential supportive data for diagnosis and assists in monitoring treatment. The Endocrine Society of Australia has developed guidelines to assist practitioners in the diagnosis and management of hypoandrogenism in younger and older men. Testosterone replacement effectively restores sexual health and other androgen dependent actions on mood/cognition, muscle and bone. Testosterone treatment in symptomatic aging men with borderline hypoandrogenism is controversial and the benefits (and risks) of testosterone therapy remain uncertain.
Similar articles
-
ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.Aging Male. 2005 Jun;8(2):59-74. doi: 10.1080/13685530500163416. Aging Male. 2005. PMID: 16096160 Review.
-
Considerations for the diagnosis and treatment of testosterone deficiency in elderly men.Am J Med. 2007 Oct;120(10):835-40. doi: 10.1016/j.amjmed.2007.02.022. Am J Med. 2007. PMID: 17904450 Review.
-
Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.Arch Neurol. 2006 May;63(5):729-35. doi: 10.1001/archneur.63.5.729. Arch Neurol. 2006. PMID: 16682542 Clinical Trial.
-
Testosterone replacement therapy for late-onset hypogonadism.Nat Clin Pract Urol. 2006 May;3(5):260-7. doi: 10.1038/ncpuro0479. Nat Clin Pract Urol. 2006. PMID: 16691239 Review.
-
Testosterone in older men after the Institute of Medicine Report: where do we go from here?Climacteric. 2005 Jun;8(2):124-35. doi: 10.1080/13697130500118001. Climacteric. 2005. PMID: 16096168 Review.
Cited by
-
Molecular effects of Moringa leaf extract on insulin resistance and reproductive function in hyperinsulinemic male rats.J Diabetes Metab Disord. 2019 Nov 15;18(2):487-494. doi: 10.1007/s40200-019-00454-7. eCollection 2019 Dec. J Diabetes Metab Disord. 2019. PMID: 31890674 Free PMC article.
-
Beneficial effects of topical testosterone replacement in patients with end-stage liver disease.Dig Dis Sci. 2004 Aug;49(7-8):1186-9. doi: 10.1023/b:ddas.0000037810.59358.d2. Dig Dis Sci. 2004. PMID: 15387344 No abstract available.
-
Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection.Onco Targets Ther. 2017 Apr 13;10:2155-2162. doi: 10.2147/OTT.S99282. eCollection 2017. Onco Targets Ther. 2017. PMID: 28458559 Free PMC article.
-
The Androgen Dehydroepiandrosterone Sulfate Shows a Greater Relationship with Impulsivity than Testosterone in a Healthy Male Sample.Brain Sci. 2024 Jun 3;14(6):569. doi: 10.3390/brainsci14060569. Brain Sci. 2024. PMID: 38928569 Free PMC article.